Article(id=1330225396785722187, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.04.021, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1634486400000, receivedDateStr=2021-10-18, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080048986, onlineDateStr=2026-11-19, pubDate=1649520000000, pubDateStr=2022-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080048986, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080048986, creator=13701087609, updateTime=1795080048986, updator=13701087609, issue=Issue{id=1330225302346773381, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='4', pageStart='347', pageEnd='484', issueExtLink='null', onlineDate='null', pubDate='1649520000000', pubDateStr='2022-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080026470, creator='13701087609', updateTime=1795084707533, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244936621994666, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244936621994667, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=480, endPage=484, ext={EN=ArticleExt(id=1330225396999631692, articleId=1330225396785722187, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Recent development in the treatment of chronic obstructive pulmonary disease with phosphodiesterase 4 inhibitors, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema disease characterized by airflow obstruction, and the morbidity and mortality are increasing year by year. Although there are many kinds of drugs for the treatment of COPD, the clinical needs of patients with COPD are still unmet. In recent years, phosphodiesterase 4 inhibitor (PDE4I) has become a research hotspot. This article reviewed the latest research progress of PDE4I, in order to provide reference for the development of clinical new drugs.
, authors=Yujie SUN
1, 2, Fenghua GU
1, 2, *, authorsList=Yujie SUN, Fenghua GU, authorCompany=null, correspAuthors=Fenghua GU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225397255484237, articleId=1330225396785722187, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=磷酸二酯酶-4抑制剂治疗慢性阻塞性肺疾病最新研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一种具有气流阻塞特征的慢性支气管炎和(或)肺气肿疾病,患病率和死亡率逐年增加。尽管临床上治疗COPD的药物种类有很多,但COPD患者的临床需求仍未得到满足。近年来,磷酸二酯酶-4抑制剂(phosphodiesterase 4 inhibitors,PDE4I)成为研究热点,现将PDE4I最新研究进展作一综述,旨在为临床新药开发提供参考。
, authors=孙玉杰
1, 2, 顾丰华
1, 2, *, authorsList=孙玉杰, 顾丰华, authorCompany=null, correspAuthors=顾丰华, authorNote=
, correspAuthorsNote=
顾丰华,副研究员,药效总监,研究方向:呼吸系统药物评价。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=7DdQfkjCEaucDewegkVVvQ==, magXml=BSQ0oa7p+Q90u0yOmUBcrA==, pdfUrl=null, pdf=1jDtYz9wGH3jQ6nEeGmz0A==, pdfFileSize=1697457, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=sHp6agodXEuyGe+W6IWr9Q==, mapNumber=null, fund=null)}, authors=[Author(id=1330225397653943125, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225397758800728, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, authorId=1330225397653943125, language=EN, stringName=Yujie SUN, firstName=Yujie, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225397825909593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, authorId=1330225397653943125, language=CN, stringName=孙玉杰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"
孙玉杰,硕士研究生,研究方向:呼吸系统药物研究。
"}, bioImg=null, bioContent=
孙玉杰,硕士研究生,研究方向:呼吸系统药物研究。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225397444227918, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, xref=1., ext=[AuthorCompanyExt(id=1330225397452616527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397444227918, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225397461005136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397444227918, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1330225397540696913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, xref=2., ext=[AuthorCompanyExt(id=1330225397549085522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397540696913, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1330225397561668435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397540696913, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1330225399465882459, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225399579128671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, authorId=1330225399465882459, language=EN, stringName=Fenghua GU, firstName=Fenghua, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, *, address=
1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225399646237536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, authorId=1330225399465882459, language=CN, stringName=顾丰华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, *, address=
1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225397444227918, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, xref=1., ext=[AuthorCompanyExt(id=1330225397452616527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397444227918, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225397461005136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397444227918, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1330225397540696913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, xref=2., ext=[AuthorCompanyExt(id=1330225397549085522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397540696913, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1330225397561668435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397540696913, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海市生物物质成药性评价技术服务平台,上海 200437)])])], keywords=[Keyword(id=1330225399746900833, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, language=EN, orderNo=1, keyword=phosphodiesterase 4 inhibitor), Keyword(id=1330225399818204002, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, language=EN, orderNo=2, keyword=chronic obstructive pulmonary disease), Keyword(id=1330225399885312867, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, language=EN, orderNo=3, keyword=research progress), Keyword(id=1330225399952421732, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, language=CN, orderNo=1, keyword=磷酸二酯酶-4抑制剂), Keyword(id=1330225400032113509, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, language=CN, orderNo=2, keyword=慢性阻塞性肺疾病), Keyword(id=1330225400095028070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, language=CN, orderNo=3, keyword=研究进展)], refs=[Reference(id=1330225400204079975, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Passi M, Shahid S, Chockalingam S. Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: implications for chronic airway diseases[J]. Int J Nanomedicine, 2020, 15: 3803-3826., articleTitle=null, refAbstract=null), Reference(id=1330225400266994536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Teferra AA, Vonk JM, Boezen HM. Longitudinal changes in airway hyperresponsiveness and COPD mortality[J]. Eur Respir J, 2020, 55(2): 1901378., articleTitle=null, refAbstract=null), Reference(id=1330225400329909097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang C, Zhou J, Wang J,
et al. Progress in the mechanism and targeted drug therapy for COPD[J]. Signal Transduct Target Ther, 2020, 5(1): 248., articleTitle=null, refAbstract=null), Reference(id=1330225400417989482, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Martin C, Burgel PR, Roche N. Inhaled dual phosphodiesterase 3/4 inhibitors for the treatment of patients with COPD: a short review[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16: 2363-2373., articleTitle=null, refAbstract=null), Reference(id=1330225400497681259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Phillips JE. Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases[J]. Front Pharmacol, 2020, 11: 259., articleTitle=null, refAbstract=null), Reference(id=1330225400577373036, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Li H, Zuo J, Tang W. Phosphodiesterase-4 inhibitors for the treatment of inflflammatory diseases[J]. Front Pharmacol, 2018, 9: 1048., articleTitle=null, refAbstract=null), Reference(id=1330225400640287598, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Lea S, Metryka A, Li J,
et al. The modulatory effects of the PDE4 inhibitors CHF6001 and roflumilast in alveolar macrophages and lung tissue from COPD patients[J]. Cytokine, 2019, 123: 154739., articleTitle=null, refAbstract=null), Reference(id=1330225400707396463, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Schick MA, Schlegel N. Clinical implication of phosphodiesterase-4 inhibition[J]. Int J Mol Sci, 2022, 23(3): 1209., articleTitle=null, refAbstract=null), Reference(id=1330225400799671152, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Rhee CK, Kim DK. Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease[J]. Korean J Intern Med, 2020, 35(2): 276-283., articleTitle=null, refAbstract=null), Reference(id=1330225400862585713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Grootendorst DC, Gauw SA, Verhoosel RM,
et al. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD[J]. Thorax, 2007, 62(12): 1081-1087., articleTitle=null, refAbstract=null), Reference(id=1330225400929694578, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Wells JM, Jackson PL, Viera L,
et al. A randomized, placebo-controlled trial of roflumilast: effect on proline-glycine-proline and neutrophilic inflammation in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2015, 192(8): 934-942., articleTitle=null, refAbstract=null), Reference(id=1330225400992609139, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Wedzicha JA, Calverley PM, Rabe KF. Roflumilast: a review of its use in the treatment of COPD[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 81-90., articleTitle=null, refAbstract=null), Reference(id=1330225401055523700, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Bateman ED, Rabe KF, Calverley PMA,
et al. Roflumilast with longacting β2-agonists for COPD: influence of exacerbation history[J]. Eur Respir J, 2011, 38(3): 553-560., articleTitle=null, refAbstract=null), Reference(id=1330225401118438261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Calverley PMA, Martinez FJ, Fabbri LM,
et al. Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol[J]. Int J Chron Obstruct Pulmon Dis, 2012, 7: 375-382., articleTitle=null, refAbstract=null), Reference(id=1330225401185547126, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Martinez FJ, Calverley PMA, Goehring UM,
et al. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial[J]. Lancet, 2015, 385(9971): 857-866., articleTitle=null, refAbstract=null), Reference(id=1330225401244267383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Matera MG, Ora J, Cavalli F,
et al. New avenues for phosphodiesterase inhibitors in asthma[J]. J Exp Pharmacol, 2021, 13: 291-302., articleTitle=null, refAbstract=null), Reference(id=1330225401319764856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Singh D, Leaker B, Boyce M,
et al. A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients[J]. Pulm Pharmacol Ther, 2016, 40: 1-6., articleTitle=null, refAbstract=null), Reference(id=1330225401391068025, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Singh D, Beeh KM, Colgan B,
et al. Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD[J]. Respir Res, 2019, 20(1): 180., articleTitle=null, refAbstract=null), Reference(id=1330225401445593978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Stellari FF, Sala A, Ruscitti F,
et al. CHF6001 inhibits NF-κB activation and neutrophilic recruitment in LPS induced lung inflammation in mice[J]. Front Pharmacol, 2019, 10: 1337., articleTitle=null, refAbstract=null), Reference(id=1330225401512702843, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Cazzola M, Calzetta L, Rogliani P,
et al. Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD[J]. Expert Opin Investig Drugs, 2019, 28(10): 827-833., articleTitle=null, refAbstract=null), Reference(id=1330225401571423100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Singh D, Martinez FJ, Watz H,
et al. A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD[J]. Respir Res, 2020, 21(1): 47., articleTitle=null, refAbstract=null), Reference(id=1330225401634337661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Franciosi LG, Diamant Z, Banner KH,
et al. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials[J]. Lancet Respir Med, 2013, 1(9): 714-727., articleTitle=null, refAbstract=null), Reference(id=1330225401697252222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Maurer B, Singh D, Martinez F,
et al. Late breaking abstract-RPL554, a first-in-class dual PDE3/4 inhibitor, causes significant bronchodilation and symptom relief; a phase 2b COPD study[J]. Eur Respir J, 2018, 52: OA1940.., articleTitle=null, refAbstract=null), Reference(id=1330225401755972479, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Bjermer L, Abbott-Banner K, Newman K. Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine)
vs salbutamol in asthma[J]. Pulm Pharmacol Ther. 2019, 58: 101814., articleTitle=null, refAbstract=null), Reference(id=1330225401831469952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Cazzola M, Calzetta L, Rogliani P,
et al. Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD[J]. Expert Opin Investig Drugs, 2019, 28(10): 827-833., articleTitle=null, refAbstract=null), Reference(id=1330225401898578817, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Calzetta L, Cazzola M, Page CP,
et al. Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways[J]. Pulm Pharmacol Ther, 2015, 32: 15-23., articleTitle=null, refAbstract=null), Reference(id=1330225401965687682, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Ferguson GT, Kerwin EM, Rheault T,
et al. A dose-ranging study of the novel inhaled dual PDE 3 and 4 inhibitor ensifentrine in patients with COPD receiving maintenance tiotropium therapy[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16: 1137-1148., articleTitle=null, refAbstract=null), Reference(id=1330225402036990851, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Singh D, Abbott-Banner K, Bengtsson T,
et al. The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD[J]. Eur Respir J, 2018, 52(5): 1801074., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225397444227918, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, xref=1., ext=[AuthorCompanyExt(id=1330225397452616527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397444227918, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225397461005136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397444227918, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1330225397540696913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, xref=2., ext=[AuthorCompanyExt(id=1330225397549085522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397540696913, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1330225397561668435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225396785722187, companyId=1330225397540696913, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海市生物物质成药性评价技术服务平台,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.04.021, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.04.021, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.04.021, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.04.021, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1649520000000, fullTextJson=null, articleText=null, reference=null)